Travere Therapeutics, Inc.
Nasdaq TVTX · San Diego, CA
Works in Cardiovascular · Dermatology · Genetic & rare · Hematology · Immunology · Metabolic & endocrine · Neurology · Ophthalmology · Renal & urogenital · Women's health
Travere Therapeutics, Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq TVTX. It has 5 active clinical trials with 296 planned participants, across 10 therapeutic areas. Since 2021 it has completed 8 trials and stopped 1 early. Its FDA record on file shows compliance actions.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq TVTX
Fundraising
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Travere Therapeutics, Inc
No warning letter naming Travere Therapeutics, Inc is on file. FDA has published other compliance actions naming it.
Travere Therapeutics, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 296 planned participants, in Cardiovascular, Dermatology, Genetic & rare, Hematology and other areas. Since 2021 it has completed 8 trials and stopped 1 early.
Travere Therapeutics, Inc is based in San Diego, CA and is listed as Nasdaq TVTX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Travere Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-14.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Travere Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.